Irish biotech GH Research has said the phase 2 win for its inhaled depression drug has “paved the way for future commercial success.” The inhaled mebufotenin candidate, dubbed GH001, was evaluated in ...

SHANGHAI, April 15, 2024 /PRNewswire/ -- The9 Limited (NCTY) ("The9"), an established Internet company, today announced that its investee WM Therapeutics Co., Ltd. (未名脑脑) ("WM Therapeutics") has ...

An experimental depression drug that joined the Neurocrine Biosciences pipeline as part of a broader package from Takeda Pharmaceutical failed to meet the main goal of a mid-stage clinical trial. The ...